NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1Social Media CoordinatorApr 121 min readCheck out this new event and grab a seat! REGISTER
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
Комментарии